HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.

AbstractBACKGROUND:
Screening for celiac disease is based on the sequential evaluation of serologic tests and intestinal biopsy; an optimal screening protocol is still under investigation. The screening policy of one of the main healthcare providers in Israel (Maccabi) consists of measuring total immunoglobulin A and tissue transglutaminase IgA antibodies and confirming positive results by endomysial antibodies. For IgA-deficient patients antigliadin IgG is measured.
OBJECTIVES:
To evaluate the use of tTGA as a first-level screening test in patients suspected of having celiac disease
METHODS:
The results of tTGA and EMA tests over a 3 month period were obtained from the laboratory computer. Letters were sent to the referring physicians of patients with positive tests, requesting clinical information and small intestinal biopsy results. tTGA was performed using an anti-guinea pig tTG-IgA enzyme-linked immunosorbent assay kit.
RESULTS:
Overall, 2,505 tTGA tests were performed: 216 (8.6%) were tTGA-positive of which 162 (75%) were EMA-negative (group 1) and 54 (25%) EMA-positive (group 2.) Clinical information was obtained for 91 patients in group 1 and 32 in group 2. Small intestinal biopsy was performed in 33 (36%) and 27 patients (84%) in groups 1 and 2, respectively. Celiac disease was diagnosed in 4 biopsies (12%) in group 1 and 23 (85%) in group 2 (P < 0.0001). The positive predictive value was 45% for tTGA and 85% for EMA.
CONCLUSIONS:
Symptomatic patients with positive tTGA and negative EMA have a low rate of celiac disease compared to those who are tTGA-positive and EMA-positive. Confirmation with EMA is advised when tTGA is performed as a first-level screening for suspected celiac disease.
AuthorsBatia Weiss, Yoram Bujanover, Benjamin Avidan, Akiva Fradkin, Ilana Weintraub, Bracha Shainberg
JournalThe Israel Medical Association journal : IMAJ (Isr Med Assoc J) Vol. 6 Issue 1 Pg. 9-12 (Jan 2004) ISSN: 1565-1088 [Print] Israel
PMID14740501 (Publication Type: Journal Article, Validation Study)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Immunoglobulin A
  • Immunoglobulin G
  • Gliadin
  • Transglutaminases
Topics
  • Adolescent
  • Adult
  • Autoantibodies (analysis, blood)
  • Bias
  • Biomarkers (analysis, blood)
  • Biopsy (methods, standards)
  • Celiac Disease (diagnosis, epidemiology, immunology, metabolism)
  • Duodenum (enzymology, immunology, pathology)
  • Enzyme-Linked Immunosorbent Assay (methods, standards)
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Gliadin (immunology)
  • Humans
  • Immunoglobulin A (analysis, blood)
  • Immunoglobulin G (analysis, blood)
  • Israel (epidemiology)
  • Male
  • Mass Screening (methods, standards)
  • Prevalence
  • Sensitivity and Specificity
  • Transglutaminases (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: